DIVISLAB's weekly performance was relatively flat, with a return of -0.02%, indicating a stable but uneventful week. The stock's volatility of 10.9% was moderate, suggesting a relatively low-risk environment. Compared to its peers, DIVISLAB outperformed DRREDDY and CIPLA but underperformed SUNPHARMA. Overall, the stock's risk profile was relatively low this week.

[Volatility: 10.9%]